Adebrelimab + Apatinib in SCLC Maintenance Therapy
Clinical trial NCT06475209 · RECRUITING
Trial details
- NCT number
- NCT06475209
- Sponsor
- Tang-Du Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2025-12-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.